Cullinan Associates Inc Pfizer Inc Transaction History

Cullinan Associates Inc

$1.81 Billion
Q3 2024

A detailed history of Cullinan Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Cullinan Associates Inc holds 64,904 shares of PFE stock, worth $1.72 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

64,904

Previous 262,084 75.24%

Holding current value

$1.72 Million

Previous $7.33 Million 74.39%

% of portfolio

0.1%

Previous 0.42%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$27.7 - $31.39 $5.46 Million - $6.19 Million	-197,180 Reduced 75.24%	64,904 $1.88 Million
Q2 2024 Jul 10, 2024	SELL	$25.26 - $29.6 $407,140 - $477,092	-16,118 Reduced 5.79%	262,084 $7.33 Million
Q1 2024 Apr 18, 2024	BUY	$25.89 - $29.73 $2.16 Million - $2.48 Million	83,384 Added 42.8%	278,202 $7.72 Million
Q4 2023 Jan 24, 2024	SELL	$26.13 - $33.94 $2.4 Million - $3.12 Million	-91,992 Reduced 32.07%	194,818 $5.61 Million
Q3 2023 Oct 11, 2023	SELL	$32.09 - $37.51 $956,282 - $1.12 Million	-29,800 Reduced 9.41%	286,810 $9.51 Million
Q2 2023 Jul 14, 2023	SELL	$36.12 - $41.79 $325,585 - $376,695	-9,014 Reduced 2.77%	316,610 $11.6 Million
Q1 2023 Apr 05, 2023	BUY	$39.39 - $51.28 $2.92 Million - $3.8 Million	74,155 Added 29.49%	325,624 $13.3 Million
Q4 2022 Jan 11, 2023	BUY	$41.75 - $54.5 $3,173 - $4,142	76 Added 0.03%	251,469 $12.9 Million
Q3 2022 Oct 19, 2022	BUY	$43.76 - $53.42 $845,968 - $1.03 Million	19,332 Added 8.33%	251,393 $11 Million
Q2 2022 Jul 08, 2022	BUY	$46.53 - $55.17 $2.16 Million - $2.56 Million	46,392 Added 24.99%	232,061 $12.2 Million
Q1 2022 Apr 21, 2022	BUY	$45.75 - $56.69 $4.2 Million - $5.21 Million	91,816 Added 97.83%	185,669 $9.61 Million
Q4 2021 Jan 07, 2022	BUY	$41.32 - $61.25 $495,137 - $733,958	11,983 Added 14.64%	93,853 $5.54 Million
Q3 2021 Oct 08, 2021	SELL	$39.25 - $50.42 $6.63 Million - $8.52 Million	-168,900 Reduced 67.35%	81,870 $3.52 Million
Q2 2021 Jul 07, 2021	SELL	$35.91 - $40.68 $1.01 Million - $1.15 Million	-28,177 Reduced 10.1%	250,770 $9.82 Million
Q1 2021 Apr 20, 2021	SELL	$33.49 - $37.77 $904 - $1,019	-27 Reduced 0.01%	278,947 $10.1 Million
Q4 2020 Jan 14, 2021	BUY	$33.47 - $42.56 $601,556 - $764,930	17,973 Added 6.89%	278,974 $10.3 Million
Q3 2020 Oct 09, 2020	BUY	$31.75 - $37.25 $127,000 - $149,000	4,000 Added 1.56%	261,001 $9.58 Million
Q2 2020 Jul 07, 2020	BUY	$30.12 - $36.54 $54,095 - $65,625	1,796 Added 0.7%	257,001 $8.4 Million
Q1 2020 Apr 01, 2020	BUY	$27.03 - $38.62 $127,473 - $182,131	4,716 Added 1.88%	255,205 $8.33 Million
Q4 2019 Jan 15, 2020	BUY	$32.92 - $37.36 $95,040 - $107,858	2,887 Added 1.17%	250,489 $9.81 Million
Q3 2019 Oct 01, 2019	SELL	$32.49 - $42.13 $30,833 - $39,981	-949 Reduced 0.38%	247,602 $8.9 Million
Q2 2019 Jul 16, 2019	BUY	$36.98 - $41.52 $270,878 - $304,134	7,325 Added 3.04%	248,551 $10.8 Million
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $165,937 - $182,310	-4,425 Reduced 1.8%	241,226 $10.2 Million
Q4 2018 Jan 11, 2019	SELL	$38.47 - $43.86 $215,432 - $245,616	-5,600 Reduced 2.23%	245,651 $10.7 Million
Q3 2018 Oct 19, 2018	SELL	$34.47 - $41.81 $821,902 - $996,917	-23,844 Reduced 8.67%	251,251 $11.1 Million
Q2 2018 Jul 09, 2018	SELL	$32.98 - $35.16 $600,236 - $639,911	-18,200 Reduced 6.21%	275,095 $9.98 Million
Q1 2018 Apr 27, 2018	SELL	$31.91 - $37.02 $504,848 - $585,693	-15,821 Reduced 5.12%	293,295 $10.4 Million
Q4 2017 Jan 17, 2018	BUY	$33.26 - $35.29 $53,216 - $56,464	1,600 Added 0.52%	309,116 $11.2 Million
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $9.53 Million - $10.5 Million	307,516	307,516 $11 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Account

Cullinan Associates Inc Pfizer Inc Transaction History